Rodrigues and Maia Campos [ 2] observed that a 15-day treatment of hairless mouse skin with glycolic acid enhanced the epithelium thickness; consequently the formulation of the present study could be suggested, since a lower concentration of this acid and a higher pH as well as the period of application were not enough to provoke a statistically significant enhancement of epithelium thickness.
Certain characteristics of Taylor flow have been frequently investigated in the literature using conventional modeling approaches but are relatively less frequently investigated using the phase field formulation, the focus of the present study.
However, levels of antibodies indicative of seroprotection were only reached with the QIV formulations in the present study.
In addition, during evaluation of 240 mg BID as the tablet formulation in the present study, the protocol of the ongoing Western phase III trial of tivantinib in advanced HCC (METIV-HCC) was amended to reduce the starting dose of tivantinib from 240 mg BID to 120 mg BID, because patients who received 240 mg BID as the tablet formulation had an increased incidence of neutropenia.
As a part of the safety evaluation of this nutraceutical formulation, the present study was carried out to determine the changes in body weight, food and water consumption, hematological parameters, serum biochemistry, and histopathological changes as indices of toxicosis with the aim of providing guidance for selecting a safe dose of its use.
The enhanced bioavailability and eliminated half-lives of Rg formulation observed in the present study are attributed to the floating nature of the designed formulations.
The aim of the present study was the formulation of a novel chewable tablet containing the non-steroidal anti-inflammatory bumadizone calcium (BZ) to deliver the drug to the colon for the local treatment of ulcerative colitis.
The results of the present study show that a provesicle formulation of an NTG MTL complex with SP and CH produced free flowing, homogeneous and smooth vesicles.
The OMV work of the present study offers a new insight into vaccine formulation.
The objective of the present study was to develop solid self-microemulsifying formulation (S-SMEF) of valsartan by spray drying (SD) and freeze drying (FD) methods and evaluate them with respect to liquid SMEF as well as marketed formulation.
